Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TransUnion (TRU) Asset Writedowns and Impairment (2016 - 2024)

TransUnion (TRU) has disclosed Asset Writedowns and Impairment for 11 consecutive years, with $2.0 million as the latest value for Q3 2022.

  • On a quarterly basis, Asset Writedowns and Impairment rose 600.0% to $2.0 million in Q3 2022 year-over-year; TTM through Sep 2022 was $3.1 million, a 203.33% increase, with the full-year FY2021 number at -$2.6 million, down 126.53% from a year prior.
  • Asset Writedowns and Impairment was $2.0 million for Q3 2022 at TransUnion, up from $200000.0 in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $6.2 million in Q1 2020 to a low of -$1.6 million in Q4 2020.
  • A 5-year average of $1.6 million and a median of $1.8 million in 2018 define the central range for Asset Writedowns and Impairment.
  • Peak YoY movement for Asset Writedowns and Impairment: plummeted 500.0% in 2020, then skyrocketed 600.0% in 2022.
  • TransUnion's Asset Writedowns and Impairment stood at $2.3 million in 2018, then crashed by 82.61% to $400000.0 in 2019, then tumbled by 500.0% to -$1.6 million in 2020, then rose by 25.0% to -$1.2 million in 2021, then surged by 266.67% to $2.0 million in 2022.
  • Per Business Quant, the three most recent readings for TRU's Asset Writedowns and Impairment are $2.0 million (Q3 2022), $200000.0 (Q2 2022), and $2.1 million (Q1 2022).